Correlation Between Denali Therapeutics and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Champions Oncology, you can compare the effects of market volatilities on Denali Therapeutics and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Champions Oncology.
Diversification Opportunities for Denali Therapeutics and Champions Oncology
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Denali and Champions is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Champions Oncology go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Champions Oncology
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 2.61 times less return on investment than Champions Oncology. But when comparing it to its historical volatility, Denali Therapeutics is 1.22 times less risky than Champions Oncology. It trades about 0.14 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest 787.00 in Champions Oncology on October 25, 2024 and sell it today you would earn a total of 285.00 from holding Champions Oncology or generate 36.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Champions Oncology
Performance |
| Timeline |
| Denali Therapeutics |
| Champions Oncology |
Denali Therapeutics and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Champions Oncology
The main advantage of trading using opposite Denali Therapeutics and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |